Market Overview - Several companies have experienced significant losses during the recent market downturn, including SeaStar Medical Holding Corporation, Li Bang International Corporation Inc., Ambipar Emergency Response, Cemtrex, Inc., and BT Brands, Inc., reflecting the broader market's susceptibility to fluctuations [1][7] SeaStar Medical Holding Corporation (ICU) - The company's stock price plummeted over 55% to $0.55, a drastic decline from its year-high of $4.55, despite ongoing clinical trials for adult acute kidney injury [2][7] - The independent Data Safety Monitoring Board reported no device-related safety issues, supporting the potential clinical benefits of the NEUTRALIZE-AKI trial [2] Li Bang International Corporation Inc. (LBGJ) - The company experienced a nearly 45% drop in stock price to $0.74, despite reporting a revenue of approximately $4.7 million for the six months ending December 31, 2024, marking a 27% increase from the previous year's $3.7 million [3][7] Ambipar Emergency Response (AMBI) - The stock price decreased by 43% to $1.93, and the company recently filed its annual report on Form 20-F for the fiscal year ending December 31, 2024, with the U.S. Securities and Exchange Commission [4][7] Cemtrex, Inc. (CETX) - The company's stock price fell over 35% to $0.40, but it has signed letters of intent for two strategic acquisitions in the robotics and aerospace sectors, which are expected to boost total annual revenues to $100 million [5][7] BT Brands, Inc. (BTBDW) - The company experienced a 33% drop in stock price to $0.17, facing significant market challenges despite its long-standing presence in the quick-service restaurant industry since 1987 [6][7]